The role of the acceptance and commitment therapy in the treatment of social anxiety: An updated scoping review.
Elisabetta Caletti, Chiara Massimo, Sara Magliocca...
https://pubmed.ncbi.nlm.nih.gov/35537544/Actively Recruiting
Led by University of Coimbra · Updated on 2026-03-10
54
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying adolescents with Oppositional Defiant Disorder ODD and Social Anxiety Disorder SAD, two conditions marked by problematic social functioning but with different outward symptoms. This research aims to evaluate the effects of Acceptance and Commitment Therapy ACT, a behavioral approach that targets underlying psychological processes common to both disorders, to see if it can improve social fears, disruptive behavior, and mental health in these adolescents. The project includes three clinical trials to test ACTs impact and similarities in treating these disorders during adolescence. The intervention, called ACTsocially, is a structured face-to-face program consisting of 11 weekly sessions of about 50 minutes each. The sessions include mindfulness exercises, reviews of prior sessions, psychoeducation, metaphors, experiential activities, and commitments for the following week. Participants include adolescents diagnosed with ODD or SAD, with some receiving ACTsocially and others serving as control groups. Assessments are conducted before and after the intervention, as well as at 3- and 6-month follow-ups. Participants will be involved in assessments measuring changes in social fears, disruptive and aggressive behaviors, psychological flexibility, and overall mental health at baseline, after 11 weeks, and during follow-up visits. The study uses questionnaires and interviews to track these outcomes and evaluates whether improvements last over time. The research team also monitors safety and adherence, ensuring that adolescents and their guardians provide informed consent and understand participation is voluntary. The study is sponsored by the University of Coimbra and runs until September 2027.
CONDITIONS
ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence
F
Francisca Alves M.Sc.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Coimbra
Lead Sponsor
Foundation for Science and Technology, Portugal
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 11 weeks
Participants receive the ACTsocially intervention consisting of 11 weekly 50-minute face-to-face sessions focused on Acceptance and Commitment Therapy to improve psychological flexibility and social functioning.
Weekly visits for 11 weeks (in-person)
Duration - 6 months
Participants are assessed to examine the stability of treatment effects at 3 and 6 months after the intervention ends.
2 visits (in-person) at 3 and 6 months post-intervention
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Elisabetta Caletti, Chiara Massimo, Sara Magliocca...
https://pubmed.ncbi.nlm.nih.gov/35537544/Andreia N Queirós, Paula Vagos
https://pubmed.ncbi.nlm.nih.gov/27427943/Jacqueline G L A-Tjak, Michelle L Davis, Nexhmedin Morina...
https://pubmed.ncbi.nlm.nih.gov/25547522/Louise Arseneault
https://pubmed.ncbi.nlm.nih.gov/29134659/Amy Orben, Livia Tomova, Sarah-Jayne Blakemore
https://pubmed.ncbi.nlm.nih.gov/32540024/Jaci L Rolffs, Ronald D Rogge, Kelly G Wilson
https://pubmed.ncbi.nlm.nih.gov/27152011/Mark B Powers, Maarten B Zum Vorde Sive Vording, Paul M G Emmelkamp
https://pubmed.ncbi.nlm.nih.gov/19142046/Whitney D Fosco, Dara E Babinski, Daniel A Waschbusch
https://pubmed.ncbi.nlm.nih.gov/36881692/Kathleen Ries Merikangas, Jian-Ping He, Marcy Burstein...
https://pubmed.ncbi.nlm.nih.gov/20855043/Paula Vagos, Diana Vieira Figueiredo, Marina Cunha
https://pubmed.ncbi.nlm.nih.gov/40759831/University of Coimbra
Lead Sponsor
Foundation for Science and Technology, Portugal
Collaborating Sponsor